Processing of ferulic acid modified hemoglobin

References

• Alam F, Yadav N, Ahmad M, Shadan M. 2014. Blood substitutes: possibilities with nanotechnology. Indian J Hematol Blood Transfus. 30:155–162.
   PubMed Web of Science ®Google Scholar
• Bobofchak Kevin M, Tarasov E, Olsen Kenneth W. 2008. Effect of cross-linker length on the stability of hemoglobin. Biochim Biophys Acta. 1784:1410–1414.
   PubMed Web of Science ®Google Scholar
• Bonaventura C, Henkens R, Alayash AI, Banerjee S, Crumbliss AL. 2013. Molecular controls of the oxygenation and redox reactions of hemoglobin. Antioxid Redox Signal. 18:2298–2313.
   PubMed Web of Science ®Google Scholar
• Cashon RE, Alayash AI. 1995. Reaction of human hemoglobin hba0 and two cross-linked derivatives with hydrogen peroxide: differential behavior of the ferryl intermediate. Arch Biochem Biophys. 316:461–469.
   PubMed Web of Science ®Google Scholar
• Cole Russell H, Vandegriff KD. 2011. MP4, a vasodilatory pegylated hemoglobin. Adv Exp Med Biol. 701:85–90.
   PubMed Web of Science ®Google Scholar
• Gould SA, Moss GS. 1996. Clinical development of human polymerized hemoglobin as a blood substitute. World J Surg. 20:1200–1207.
   PubMed Web of Science ®Google Scholar
• Gu J, Chang TMS. 2009. Extraction of erythrocyte enzymes for the preparation of polyhemoglobin-catalase-superoxide dismutase. Artif Cells Blood Substit Immobil Biotechnol. 37:69–77.
   PubMed Web of Science ®Google Scholar
• Hovanessian AG, Awdeh ZL. 1976. Gel isoelectric focusing of human-serum transferrin. Eur J Biochem. 68:333–338.
   PubMedGoogle Scholar
• Mathew S, Abraham T. 2004. Ferulic acid: an antioxidant found naturally in plant cell walls and feruloyl esterases involved in its release and their applications. Crit Rev Biotechnol. 24:59–83.
   PubMed Web of Science ®Google Scholar
• Nagababu E, Ramasamy S, Rifkind JM, Jia Y, Alayash AI. 2002. Site-specific cross-linking of human and bovine hemoglobins differentially alters oxygen binding and redox side reactions producing rhombic heme and heme degradation. Biochemistry. 41:7407–7415.
   PubMed Web of Science ®Google Scholar
• Nicholson SK, Tucker GA, Brameld JM. 2008. Effects of dietary polyphenols on gene expression in human vascular endothelial cells. Proc Nutr Soc. 67:42–47.
   PubMed Web of Science ®Google Scholar
• Quebec EA, Chang TMS. 1995. Superoxide dismutase and catalase cross-linked to polyhemoglobin reduces methemoglobin formation in vitro. Artif Cells Blood Substit Immobil Biotechnol. 23:693–705.
   PubMed Web of Science ®Google Scholar
• Raat NJH, Ince C. 2007. Oxygenating the microcirculation: the perspective from blood transfusion and blood storage. Vox Sang. 93:12–18.
   PubMed Web of Science ®Google Scholar
• Sakai H. 2014. Biocompatibility of a highly concentrated fluid of hemoglobin-vesicles as a transfusion alternative. Regener Med Artif Cells Nanomed. 3:133–147.
   Google Scholar
• Sakai H, Okuda N, Takeoka S, Tsuchida E. 2011. Increased viscosity of hemoglobin-based oxygen carriers retards no-binding when perfused through narrow gas-permeable tubes. Microvasc Res. 81:169–176.
   PubMed Web of Science ®Google Scholar
• Sakai H. 2012. Present situation of the development of cellular-type hemoglobin-based oxygen carrier (hemoglobin-vesicles). Curr Drug Discov Technol. 9:188–193.
   PubMedGoogle Scholar
• Sato T, Sakai H, Sou K, Medebach M, Glatter O, Tsuchida E. 2009. Static structures and dynamics of hemoglobin vesicle (HBV) developed as a transfusion alternative. J Phys Chem B. 113:8418–8428.
   PubMed Web of Science ®Google Scholar
• Snell SM, Marini MA. 1988. A convenient spectroscopic method for the estimation of hemoglobin concentrations in cell-free solutions. J Biochem Biophys Methods. 17:25–33.
   PubMedGoogle Scholar
• Tsai AG, Intaglietta M, Sakai H, Delpy E, La Rochelle CD, Rousselot M, Zal F. 2012. Microcirculation and NO-CO studies of a natural extracellular hemoglobin developed for an oxygen therapeutic carrier. Curr Drug Discov Technol. 9:166–172.
   PubMedGoogle Scholar
• Vandegriff KD, Medina F, Marini MA, Winslow RM. 1989. Equilibrium oxygen binding to human hemoglobin cross-linked between the α chains by bis(3,5-dibromosalicyl) fumarate. J Biol Chem. 264:17824–17833.
   PubMed Web of Science ®Google Scholar
• Walder RY, Andracki ME, Walder JA. 1994. Preparation of intramolecularly cross-linked hemoglobins. Meth Enzymol. 231:274–280.
   PubMed Web of Science ®Google Scholar
• Walter SV, Chang TMS. 1990. Chronotropic effects of in vitro perfusion with albumin, stroma-free hemoglobin, and polyhemoglobin solutions. Biomater Artif Cells Artif Organs. 18:283–298.
   PubMed Web of Science ®Google Scholar
• Wang MY, Yu YT, Chang TMS. 2005. New method for preparing more stable microcapsules for the entrapment of genetically engineered cells. Artif Cells Blood Substit Immobil Biotechnol. 33:257–269.
   PubMed Web of Science ®Google Scholar
• Yu WP, Chang TMS. 1996. Submicron polymer membrane hemoglobin nanocapsules as potential blood substitutes: preparation and characterization. Artif Cells Blood Substit Immobil Biotechnol. 24:169–183.
   PubMed Web of Science ®Google Scholar
• Zhang R, Xiang Y, Ran Q, Deng X, Xiao Y, Xiang L, Li Z. 2014. Involvement of calcium, reactive oxygen species, and atp in hexavalent chromium-induced damage in red blood cells. Cell Physiol Biochem. 34:1780–1791.
   PubMed Web of Science ®Google Scholar
• Zhu H, Du Q, Chen C, Chang TMS. 2010. The immunological properties of stroma-free polyhemolysate containing catalase and superoxide dismutase activities prepared by polymerized bovine stroma-free hemolysate. Artif Cells Blood Subst Biotechnol. 38:57–63.
   PubMed Web of Science ®Google Scholar